ICON plc - Clinical Research Organisation (CRO) for Drug Development

Live Active Patient EHR Data

ICON and Practice Fusion extend partnership to provide live Active Patient EHR data for clinical records.

Considerations for Parkinson’s Disease Trials

Aspects of Parkinson’s Disease studies that sponsors should bear in mind as they plan their clinical trials.

FIRECREST

Site performance ignited: Digital solutions increase efficiency in clinical trials by driving site performance.

ICON Insights

04 July 2018

What Motivates Patients to Participate in Multiple Clinical Trials?

Successful clinical trial recruitment requires a thorough understanding of the target patient profile, and a key factor within this profile is patient motivation.

25 June 2018

FDA Acceptance of Clinical Data Collected Outside the U.S.

The US Food & Drug Administration (FDA) amended requirements for the acceptance of clinical data cllected outside the US to support medical device submissions.

21 June 2018

Harnessing Blockchain Technology and Digital Disruption

The opportunity for blockchain in healthcare and clinical trials.

15 June 2018

The Future of Automation and Digital Transformation in Late Phase Research

Late phase studies are ripe for digitalisation, although not always in the same ways as Phase II and III programs.

14 June 2018

Biostatistics: Using Restricted Mean Survival Time (RMST) in Oncology Trials to Improve Outcomes

Learn how to use biostatistics using RMST in Oncological trials to improve clinical outcomes

11 June 2018

NASH Clearing Clinical Trial Hurdles in Race to $35 billion Market

NASH ranks among the world’s great emerging health threats

07 June 2018

Controlling Logistics Costs Can Significantly Reduce Trial Lab Expenses

ICON has developed a lab logistics program to reduce costs

07 June 2018

Making the Move to Virtual Clinical Trials

Late phase research, once the exception, is becoming the rule. Some post marketing evidence needs can be met with virtual studies, DtP and cyber studies.

30 May 2018

Data-driven Site Selection Aids Accelerated Study Start-Up

There is an increasing demand from sponsors for technology and data-driven solutions to improve site selection, study start- up and patient recruitment.

Services

Therapeutics

Innovation

Insights

News & Events

About ICON

Improving Pharma R&D Efficiency

Disruptive Innovation – The Impact

Value Based Healthcare

Immuno-Oncology